Equities

Meditera Tibbi Malzeme Sanayi ve Ticaret AS

MEDTR.E:IST

Meditera Tibbi Malzeme Sanayi ve Ticaret AS

Actions
Health CareMedical Equipment and Services
  • Price (TRY)51.00
  • Today's Change-0.20 / -0.39%
  • Shares traded363.38k
  • 1 Year change+37.61%
  • Beta0.8424
Data delayed at least 15 minutes, as of Nov 22 2024 15:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Meditera Tibbi Material Industry and Trade AS is a Turkey-based company, which engages in medical equipment manufacturing. The main activities of the entity consist of manufacturing and sale of medical devices (respiratory systems and infusion systems), drug preparation systems, surgical sutures (surgical sutures), biocidal products and other medical supplies. In addition to all the Company offers necessary technical service, consultancy and training. Meditera produces in its 14,840 square meter production facility with an annual capacity of 4,437 pallets and exports its products to more than 80 countries. The Company, Internacional Farmaceutica S.A. de C.V. S & Mohr company, which was established as a joint venture with (IFSA) company, manufactures surgical sutures in its facilities in Turkey, and S & Mohr America manufactures breathing circuits and accessories in its facilities in Mexico.

  • Revenue in TRY (TTM)2.08bn
  • Net income in TRY-184.66m
  • Incorporated1996
  • Employees769.00
  • Location
    Meditera Tibbi Malzeme Sanayi ve Ticaret ASTire OSBIZMIR 35900TurkeyTUR
  • Phone+90 2 325135110
  • Fax+90 2 322539404
  • Websitehttps://www.meditera.com.tr
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pulsion Medical Systems SE1.14bn195.13m4.89bn71.0024.894.8519.904.270.65490.65493.843.360.97111.773.88446,048.4016.5819.8221.2429.7263.6650.4217.0721.571.7715.740.00--20.697.87-399.21----0.00
EKF Diagnostics Holdings PLC2.21bn207.18m4.96bn309.0023.951.6611.442.240.01050.01050.11230.15160.63073.016.99160,728.706.345.207.356.1348.0550.0410.057.913.081,703.500.0175113.68-21.054.34123.28-25.3030.37--
EasyMotionSkin Tec GmbH-3.61tn-3.61tn5.15bn17.00------------------------------------------------229.95---214.79------
Nordhealth As1.58bn-298.14m5.24bn403.00--3.3257.593.32-1.23-1.236.5011.210.475--9.491,282,595.00-8.98---10.01--85.89---18.91------0.00--18.60--21.96------
Amplitude Surgical SA3.83bn55.15m5.30bn428.0096.171.5310.491.390.03180.03182.212.000.38890.53878.20247,707.900.56050.44120.66870.5279.3677.841.441.281.090.69590.5503--5.810.6658-96.11--2.62--
Genovis AB404.16m86.95m5.55bn32.0063.808.0145.4613.730.42630.42631.983.390.4239----3,506,189.009.1218.569.8021.4564.6965.5121.5123.88----0.25550.0054.5435.56449.56--47.59--
Stille AB1.52bn158.45m5.79bn151.0032.712.7724.803.826.336.3360.9474.850.69782.108.494,598,368.007.287.038.708.1949.1743.9310.439.851.127.410.0021.9819.7016.78-2.485.3423.62--
Lumibird SA7.35bn257.20m5.92bn1.05k20.510.84686.700.80570.35590.35599.148.620.52381.094.05193,497.101.833.132.443.9961.6861.763.505.891.622.470.42870.006.6015.12-37.23-2.4718.34--
Aoti Inc1.70bn-322.89m5.98bn80.00--11.32--3.51-0.07-0.070.36910.11451.563.578.18327,156.20-29.55---41.81--85.76---18.96--2.57-3.080.4812--31.06---191.92------
Meditera Tibbi Mlzm Sny Tcrt AS2.08bn-184.66m6.09bn769.00--2.90--2.93-1.55-1.5517.5017.631.043.505.542,860,310.00-9.278.88-11.2410.9140.3143.51-8.889.852.43--0.0253181.79-8.9948.75-77.3815.68----
Prim SA8.21bn412.42m6.11bn901.0014.801.337.580.74450.67170.671713.377.461.141.964.39252,736.005.736.688.348.9038.2838.115.026.431.13--0.13159.389.7710.0051.02-2.1412.86-5.01
Detection Technology Oyj-3.61tn-3.61tn7.35bn464.00--2.76----------5.03----------9.34--11.96--47.44--8.223.39--0.0053.455.292.027.55-18.03-14.88-9.55
BICO Group AB7.02bn-2.45bn7.45bn828.00--0.8285--1.06-11.15-15.2031.9241.790.36022.154.472,547,964.00-12.62---14.44--55.70---35.03--2.23-0.57050.397--6.09---1,889.33------
Onward Medical NV0.00-1.27bn7.51bn99.00--7.67-----1.09-1.090.000.60790.00----0.00-66.40-55.70-79.20-61.60-------79,513.95----0.4855---34.62---10.40--32.59--
Medistim ASA1.70bn316.33m8.05bn152.0025.416.3720.424.735.555.5529.8722.121.130.74617.483,599,204.0021.0522.9325.5328.5279.1278.2518.5820.642.75--0.018175.257.0010.06-8.9112.720.03314.87
Data as of Nov 22 2024. Currency figures normalised to Meditera Tibbi Malzeme Sanayi ve Ticaret AS's reporting currency: Turkish Lira TRY

Institutional shareholders

5.31%Per cent of shares held by top holders
HolderShares% Held
Azimut Portf�y Y�netimi ASas of 14 Aug 20246.26m5.26%
HSBC Portf�y Y�netim ASas of 31 Jul 202444.70k0.04%
IS Portfoy Yonetimi ASas of 31 Jul 202115.68k0.01%
American Century Investment Management, Inc.as of 07 Nov 20241.50k0.00%
More ▼
Data from 31 Dec 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.